Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

2003 • 3,707 citations

Circulating angiogenic factors and the risk of preeclampsia*

2004 • 2,591 citations

Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer

2002 • 1,699 citations

Vascular Endothelial Growth Factor Ligands and Receptors That Regulate Human Cytotrophoblast Survival Are Dysregulated in Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome

2002 • 637 citations

Recent Insights into the Pathogenesis of Pre-eclampsia

2002 • 603 citations

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

2003 • 519 citations

Birthweight by gestational age in Norway

2000 • 506 citations

Overexpression of the Soluble Vascular Endothelial Growth Factor Receptor in Preeclamptic Patients: Pathophysiological Consequences

2003 • 453 citations

First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia

2004 • 450 citations

Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies

2003 • 411 citations

Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia

2003 • 396 citations

Pitfalls in the Measurement of Circulating Vascular Endothelial Growth Factor

2001 • 325 citations

Preeclampsia is associated with reduced serum levels of placenta growth factor

1998 • 289 citations

Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies

2001 • 230 citations

Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia

2003 • 220 citations

Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia

1995 • 208 citations

Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre‐eclampsia

1999 • 192 citations

Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre‐eclampsia

1997 • 158 citations

Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre‐eclampsia

1996 • 137 citations

Amniotic fluid–soluble vascular endothelial growth factor receptor-1 in preeclampsia

2000 • 133 citations

Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors.

2001 • 107 citations

Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal–fetal interface in the mouse placenta

2003 • 75 citations

Maternal and Transplacental Effects of Cocaine

1998 • 39 citations

Amniotic Fluid–Soluble Vascular Endothelial Growth Factor Receptor-1 in Preeclampsia

2000 • 33 citations

Angiogenic Factors in Preeclampsia

2017 • 5 citations